Aker BioMarine ASA (OSL:AKBM)

Aker BioMarine ASA Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	8,946	8,656	5,884	4,033	3,335	4,756
Market Cap Growth	56.23%	47.13%	45.89%	20.94%	-29.89%	-53.79%
Enterprise Value	10,612	10,398	7,308	8,170	7,246	7,421
Last Close Price	102.00	98.70	67.10	25.59	21.16	30.20
PE Ratio	-	-	2.87	-	33.85	-
Forward PE	49.26	39.34	179.33	80.58	30.13	-
PS Ratio	4.07	3.94	2.60	2.03	1.22	2.06
PB Ratio	6.17	5.97	2.98	1.09	0.89	1.46
P/TBV Ratio	32.87	31.80	7.96	1.85	1.54	2.68
P/FCF Ratio	-	-	-	265.14	-	-
P/OCF Ratio	201.69	195.16	42.45	8.39	22.42	207.63
EV/Sales Ratio	4.83	4.73	3.23	4.10	2.65	3.21
EV/EBITDA Ratio	19.71	19.32	16.45	84.81	12.04	21.88
EV/EBIT Ratio	82.89	81.22	-	-	45.12	-
EV/FCF Ratio	-619.24	-	-	537.11	-	-
Debt / Equity Ratio	1.27	1.27	0.85	1.07	1.01	0.88
Debt / EBITDA Ratio	3.41	3.41	3.58	27.68	5.82	7.37
Debt / FCF Ratio	-	-	-	262.00	-	-
Net Debt / Equity Ratio	1.15	1.15	0.76	1.00	0.95	0.85
Net Debt / EBITDA Ratio	3.10	3.10	3.39	38.47	5.87	8.15
Net Debt / FCF Ratio	-97.23	-97.23	-25.48	243.67	-14.13	-4.12
Asset Turnover	0.56	0.56	0.33	0.24	0.35	0.36
Inventory Turnover	1.18	1.18	0.93	0.65	0.97	1.38
Quick Ratio	0.83	0.83	1.21	0.83	0.84	0.93
Current Ratio	2.47	2.47	3.79	2.57	2.85	3.10
Return on Equity (ROE)	-1.76%	-1.76%	-5.29%	-8.67%	2.67%	-2.15%
Return on Assets (ROA)	2.06%	2.06%	-0.55%	-0.78%	1.29%	-0.59%
Return on Invested Capital (ROIC)	4.01%	4.13%	-1.02%	-1.40%	1.88%	-1.07%
Return on Capital Employed (ROCE)	4.10%	4.10%	-1.60%	-1.40%	2.30%	-1.00%
Earnings Yield	-2.57%	-2.66%	34.81%	-2.26%	2.95%	-1.48%
FCF Yield	-0.19%	-0.20%	-1.00%	0.38%	-7.50%	-14.10%
Buyback Yield / Dilution	-	-	-0.02%	-0.04%	-0.05%	-12.20%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.